We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > The University of Oxford

News List

Phase III trial to study REGN-COV2, potential COVID-19 antibody treatment europeanpharmaceuticalreview
September 17, 2020
REGN-COV2 will be evaluated alongside standard-of-care in a Phase III study as part of the COVID-19 RECOVERY trial.
Researchers say hydroxychloroquine could still prevent COVID-19 pharmatimes
August 11, 2020
Leading scientific researchers from the University of Oxford have said that the antiviral medication hydroxychloroquine is being ‘discarded prematurely’ and could still have benefit against COVID-19.
Project leader: Oxford’s COVID-19 vaccine trial has 50 per cent chance of success expresspharma
May 27, 2020
The experimental vaccine, known as ChAdOx1 nCoV-19, is one of the front-runners in the global race to provide protection against the new coronavirus causing the COVID-19 pandemic.